Cardiovascular Devices Market – Trends Forecast Till 2031

1
Cardiovascular Devices Market Trends and
Forecast Till 2031
sales_at_delvens.com www.delvens.com
2
Cardiovascular Devices Market Trends and
Forecast Till 2031
Cardiovascular Devices Market, By Product
(Diagnostic Monitoring (ECG, Holter), Surgical
Devices (Pacemakers, Stents)) and region (North
America, Europe, Asia-Pacific, Middle East and
Africa and South America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/veterinary
-vaccines-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
The cardiovascular devices market refers to the
industry involved in the manufacturing,
distribution, and innovation of medical devices
used in the diagnosis, treatment, and prevention
of cardiovascular diseases (CVDs). This market
includes a wide range of products such as stents,
pacemakers, heart valves, defibrillators,
catheters, and diagnostic imaging devices. As
cardiovascular diseases remain one of the leading
causes of death worldwide, the demand for
effective and advanced medical solutions has
driven the growth of this market. The market is
heavily influenced by technological advancements,
rising awareness of heart-related diseases, and
the increasing prevalence of risk factors such as
hypertension, diabetes, and obesity. Purchase
this Report https//www.delvens.com/checkout/card
iovascular-devices-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The scope of the cardiovascular devices market
extends across a variety of applications,
including diagnostics, treatment, and monitoring
of heart conditions. These devices are used in
both surgical and non-surgical procedures,
helping physicians to diagnose issues like
coronary artery disease, heart failure,
arrhythmias, and valve disorders.  Recent trends
in the cardiovascular devices market include the
integration of advanced technologies like
artificial intelligence (AI), robotics, and 3D
printing into device development. These
innovations are contributing to the creation of
more precise, efficient, and personalized
cardiovascular treatments. There is also a
notable trend towards the development of
bioresorbable devices, which offer the potential
for reduced complications and eliminate the need
for long-term implantation. Key drivers of the
cardiovascular devices market include the aging
global population, increasing urbanization, and
the rise in lifestyle-related diseases, which are
contributing to a higher incidence of
cardiovascular conditions. Additionally,
advancements in healthcare infrastructure and the
availability of better reimbursement policies in
various countries are supporting market growth.
Growing awareness campaigns aimed at educating
the public about heart health and the increasing
adoption of advanced treatment protocols are also
driving the demand for cardiovascular devices.
sales_at_delvens.com
www.delvens.com
5
Key Findings
In terms of product segments, the market is
divided into diagnostic monitoring devices and
surgical devices. The surgical devices segment,
which includes products like cardiac
resynchronization therapy devices, pacemakers,
coronary stents, and valves, currently holds the
largest revenue share. The market is also divided
into various regions such as North America,
Europe, Asia-Pacific, South America, and Middle
East and Africa. North America region is
projected to hold the largest market share.
Factors such as rising prevalence of
cardiovascular diseases, aging population, demand
for minimally invasive procedures, technological
advancements, improved healthcare infrastructure,
increased awareness, favorable reimbursement
policies, lifestyle risk factors, advancements in
personalized medicine, and regulatory support
have triggered the Global Cardiovascular Devices
Market in the region. Inquire Before Buying
https//www.delvens.com/Inquire-before-buying/card
iovascular-devices-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• Abbott
• GE HealthCare
• Edwards Lifesciences Corporation
• W. L. Gore Associates, Inc.
• Siemens Healthcare GmbH
• BIOTRONIK SE Co. KG
• Canon Medical Systems Asia Pte. Ltd.
• B. Braun SE
• LivaNova PLC

• Cardinal Health
• Medtronic
• Boston Scientific Corporation

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In October 2024, Koninklijke Philips N.V.
showcased its innovative cardiology solutions at
the Transcatheter Cardiovascular Therapeutics
(TCT) annual meeting. These advancements were
designed to boost clinical confidence, improve
procedural efficiency, and enhance patient
outcomes in interventional procedures, with the
goal of providing better care to a broader
patient population. In April 2024, Medtronic
launched its latest breakthrough in cardiac
surgery, the Avalus Ultra valve. This advanced
surgical aortic tissue valve is designed to
simplify implantation and optimize long-term
patient management. In March 2024, Stryker
unveiled the LIFEPAK CR2 AED and an Evacuation
Chair for cardiac care. The LIFEPAK CR2 aids
rescuers in delivering rapid CPR and shock during
sudden cardiac arrest, featuring QUIK-STEP
electrodes for quick placement and a Shock
Advisory System for ECG analysis.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com